{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:12:05Z","timestamp":1791209525060,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"straZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.06.018","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T20:25:08Z","timestamp":1594067108000},"page":"1114-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"John D.","family":"Pauling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.018_bib0001","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.018_bib0002","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.semarthrit.2018.08.001","article-title":"Exploring the patient experience of digital ulcers in systemic sclerosis","volume":"48","author":"Hughes","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.018_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/1744666X.2018.1464390","article-title":"The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis","volume":"14","author":"Pauling","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0004","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2665-9913(19)30079-7","article-title":"Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials","volume":"1","author":"Khouri","year":"2019","journal-title":"The Lancet Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2397198318764796","article-title":"Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design","volume":"3","author":"Hughes","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.018_bib0006","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201201-0006PP","article-title":"Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials","volume":"185","author":"Raghu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0007","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"Bmj"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0008","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0009","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.018_bib0011","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1136\/annrheumdis-2012-201536","article-title":"A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon","volume":"72","author":"Hummers","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1016\/j.semarthrit.2020.06.018_bib0012","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.018_bib0013","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.131284","article-title":"Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis","volume":"41","author":"Cutolo","year":"2014","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.018_bib0014","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3899\/jrheum.160592","article-title":"Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis","volume":"43","author":"Trombetta","year":"2016","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.018_bib0015","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.1780331103","article-title":"The post-occlusive hyperemic response in patients with systemic sclerosis","volume":"33","author":"Wigley","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.018_bib0016","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.freeradbiomed.2006.01.014","article-title":"Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis","volume":"40","author":"Cracowski","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.018_bib0017","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3899\/jrheum.091356","article-title":"Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study","volume":"37","author":"Cutolo","year":"2010","journal-title":"J Rheumatol"},{"issue":"6673","key":"10.1016\/j.semarthrit.2020.06.018_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study","volume":"298","author":"Rademaker","year":"1989","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0019","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/keu300","article-title":"Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan","volume":"54","author":"Meijs","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 106(4)","key":"10.1016\/j.semarthrit.2020.06.018_bib0020","first-page":"151","article-title":"Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study","volume":"35","author":"Andrigueti","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.018_bib0021","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40123","article-title":"The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"69","author":"Bello","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13075-015-0558-9","article-title":"Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: a 12-week randomized double-blind placebo controlled trial","volume":"17","author":"Bose","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.018_bib0023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.rbre.2014.09.001","article-title":"Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: A randomized, double-blind, placebo-controlled clinical trial","volume":"54","author":"Correa","year":"2014","journal-title":"Revista Brasileira de Reumatologia (English Edition)"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0024","first-page":"499","article-title":"Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study","volume":"18","author":"Denton","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.018_bib0025","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","article-title":"Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial","volume":"42","author":"Dziadzio","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.018_bib0026","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3899\/jrheum.100358","article-title":"Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension","volume":"37","author":"Rosato","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0027","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fphar.2019.00293","article-title":"Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study","volume":"10","author":"Ruaro","year":"2019","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0028","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/039463200501800420","article-title":"Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon","volume":"18","author":"Salsano","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.018_bib0029","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/j.1552-4604.1987.tb05587.x","article-title":"Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects","volume":"27","author":"Wollersheim","year":"1987","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.018_bib0030","first-page":"2389","article-title":"Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation","volume":"26","author":"Khan","year":"1999","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.018_bib0031","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/41.3.324","article-title":"Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis","volume":"41","author":"Anderson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.018_bib0032","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2004.09.032","article-title":"Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement","volume":"38","author":"Cracowski","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.018_bib0033","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/acr.21622","article-title":"Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon","volume":"64","author":"Fava","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.018_bib0034","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/ket421","article-title":"A double-blind, randomized, placebo-controlled crossover trial of the alpha2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis","volume":"53","author":"Herrick","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.018_bib0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/micc.12272","article-title":"Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis","volume":"23","author":"Gaillard-Bigot","year":"2016","journal-title":"Microcirculation"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.018_bib0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/rheumatology\/kem314","article-title":"Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis?","volume":"47","author":"Murray","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.018_bib0037","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-009-1157-4","article-title":"No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis","volume":"28","author":"Hettema","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0038","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar4216","article-title":"Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion","volume":"15","author":"Shah","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0039","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/03009742.2017.1397187","article-title":"Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study","volume":"47","author":"Rotondo","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mvr.2016.12.008","article-title":"Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate","volume":"111","author":"Hughes","year":"2017","journal-title":"Microvasc Res"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0041","first-page":"1","article-title":"A feasibility study of a novel low-level light therapy for digital ulcers in systemic sclerosis","author":"Hughes","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0042","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mvr.2015.06.009","article-title":"Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients","volume":"101","author":"Ruaro","year":"2015","journal-title":"Microvasc Res"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.018_bib0043","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1007\/s00296-011-2183-5","article-title":"Increased finger skin vasoreactivity and stimulated vasomotion associated with simvastatin therapy in systemic sclerosis hypercholesterolemic patients","volume":"32","author":"Rossi","year":"2012","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0044","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/0001555576144146","article-title":"Clinical aspects of the use of gamma linolenic acid in systemic sclerosis","volume":"76","author":"Stainforth","year":"1996","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.018_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/acr.21858","article-title":"Evaluation of Test Characteristics for Outcome Measures Used in Raynaud's Phenomenon Clinical Trials","volume":"65","author":"Gladue","year":"2013","journal-title":"Arthritis Care & Research"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.018_bib0046","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.180818","article-title":"Factors influencing Raynaud's condition score diary outcomes in systemic sclerosis","volume":"46","author":"Pauling","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.018_bib0047","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.40457","article-title":"A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon","volume":"70","author":"Wilkinson","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0048","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semarthrit.2019.08.007","article-title":"The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: A systematic review","volume":"50","author":"Melsens","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0049","unstructured":"Administration, U.S.D.o.H.a.H.S.F.a.D. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009 [06\/01\/2016]; Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf."},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.018_bib0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3899\/jrheum.141437","article-title":"Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary","volume":"42","author":"Pauling","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.018_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa037","article-title":"Patient experiences of digital ulcer development and evolution in systemic sclerosis","author":"Hughes","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.018_bib0052","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/acr.23729","article-title":"Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity","volume":"71","author":"Pauling","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.018_bib0053","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acr.24127","article-title":"A Multi-Centre Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis","volume":"72","author":"Hughes","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.018_bib0054","first-page":"278","article-title":"Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial","volume":"14","author":"Wise","year":"1987","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:39Z","timestamp":1758733599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220301979"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.018","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}